Dennis J. Montoya, Ph.D.
Affiliations: | 2009 | University of California, Los Angeles, Los Angeles, CA |
Area:
ImmunologyGoogle:
"Dennis Montoya"Parents
Sign in to add mentor| Robert L. Modlin | grad student | 2009 | UCLA | |
| (Intersection of lipid metabolism and the innate immune response to mycobacterial infection.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| R Andrade P, Mehta M, Lu J, et al. (2019) The cell fate regulator NUPR1 is induced by Mycobacterium leprae via type I interferon in human leprosy. Plos Neglected Tropical Diseases. 13: e0007589 |
| Kim EW, De Leon A, Jiang Z, et al. (2019) Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis. Msphere. 4 |
| Montoya DJ, Andrade P, Silva BJA, et al. (2019) Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune Response. Cell Reports. 26: 3574-3585.e3 |
| Avni E, Montoya D, Lopez D, et al. (2018) A phylogenomic study quantifies competing mechanisms for pseudogenization in prokaryotes-The Mycobacterium leprae case. Plos One. 13: e0204322 |
| Montoya D, Mehta M, Ferguson BG, et al. (2018) Plasticity of antimicrobial and phagocytic programs in human macrophages. Immunology |
| Lopez D, Montoya D, Ambrose M, et al. (2017) SaVanT: a web-based tool for the sample-level visualization of molecular signatures in gene expression profiles. Bmc Genomics. 18: 824 |
| Kibbie J, Teles RM, Wang Z, et al. (2016) Jagged1 Instructs Macrophage Differentiation in Leprosy. Plos Pathogens. 12: e1005808 |
| Lam L, Chin L, Halder RC, et al. (2016) Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Montoya D, Inkeles MS, Liu PT, et al. (2014) IL-32 is a molecular marker of a host defense network in human tuberculosis. Science Translational Medicine. 6: 250ra114 |
| Schenk M, Fabri M, Krutzik SR, et al. (2014) Interleukin-1β triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to T cells. Immunology. 141: 174-80 |